Cambridge Nutritional Sciences plc
CNSL.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | £7,267 | £8,083 | £7,169 | £7,032 |
| - Cash | £4,868 | £2,943 | £5,115 | £1,605 |
| + Debt | £349 | £148 | £74 | £370 |
| Enterprise Value | £2,748 | £5,288 | £2,128 | £5,797 |
| Revenue | £8,330 | £9,774 | £7,546 | £8,539 |
| % Growth | -14.8% | 29.5% | -11.6% | – |
| Gross Profit | £5,005 | £6,046 | £3,173 | £4,749 |
| % Margin | 60.1% | 61.9% | 42% | 55.6% |
| EBITDA | £2,198 | -£73 | -£2,648 | -£382 |
| % Margin | 26.4% | -0.7% | -35.1% | -4.5% |
| Net Income | £1,566 | -£328 | -£3,860 | -£11,333 |
| % Margin | 18.8% | -3.4% | -51.2% | -132.7% |
| EPS Diluted | 0.007 | -0.001 | -0.017 | -0.062 |
| % Growth | 571.4% | 91.6% | 73.1% | – |
| Operating Cash Flow | £83 | £607 | -£3,152 | -£3,229 |
| Capital Expenditures | -£225 | -£59 | -£153 | -£1,478 |
| Free Cash Flow | -£142 | £548 | -£3,305 | -£4,707 |